Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 7;21(1):1191-1193.
doi: 10.1007/s40200-022-00994-5. eCollection 2022 Jun.

Diabetes and COVID-19: a bitter nightmare

Mandana Hasanzad  1   2 , Bagher Larijani  3 , Hamid Reza Aghaei Meybodi  2   4
Affiliations
Editorial

Diabetes and COVID-19: a bitter nightmare

Mandana Hasanzad et al. J Diabetes Metab Disord. .

Abstract

Initial studies found a bidirectional interaction between coronavirus disease 2019 (COVID-19) and diabetes. In this article we intend to review the association and consequences of COVID-19 in the future of diabetes in case of prevalence and treatment. There is substantial evidence that COVID-19 may result in the new-onset of hyperglycaemia. Therefore, it seems that COVID-19 will change the predictions for the prevalence of diabetes. Moreover, it raises numerous challenges for the clinical management of diabetes. In COVID-19 patients, new-onset hyperglycemia is associated with a poor prognosis. Diabetes mellitus and other comorbidities should be strictly controlled. But, with the emergence of COVID-19 disease, the future of diabetes mellitus in terms of prevalence and treatment will change and policymakers should consider developing new management strategies in this regard.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-022-00994-5.

Keywords: COVID-19; Diabetes; Hyperglycemia; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declared that they have no conflict of interest.

References

    1. World Health Organization (WHO). Coronavirus disease (COVID-19). https://covid19.who.int/
    1. Codo AC, Davanzo GG, de Brito Monteiro L, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32(3):437–46. doi: 10.1016/j.cmet.2020.07.007. - DOI - PMC - PubMed
    1. Yang J, Feng Y, Yuan M, Yuan S, Fu H, Wu B, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–8. doi: 10.1111/j.1464-5491.2006.01861.x. - DOI - PubMed
    1. Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020;167:108382. doi: 10.1016/j.diabres.2020.108382. - DOI - PMC - PubMed
    1. American Diabetes Association (ADA). 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2020;43(Supplement 1):S14-S31. - PubMed

Publication types

LinkOut - more resources